(Reuters) - Medical device maker Zimmer Holdings Inc said it would buy orthopedic products company Biomet Inc in a deal valued at about $13.35 billion to broaden its portfolio of products that treat bone and joint-related disorders. Zimmer will pay $10.35 billion in cash and issue $3 billion in shares to Biomet shareholders. Biomet was taken private for $11.4 billion in 2007 by a private equity consortium including affiliates of Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co and TPG. Biomet was advised by BofA Merrill Lynch, Goldman Sachs, Cleary Gottlieb Steen & Hamilton LLP and Weil, Gotshal & Manges LLP.
BEIRUT (AP) — Syrian government airstrikes targeted a vegetable market in a rebel-held town in the northern Aleppo province on Thursday, killing at least 18 people and wounding scores of others, opposition activists said.